Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a US$5 million drawdown under ...

Paradigm Biopharmaceuticals ( ($AU:PAR) ) just unveiled an announcement. Paradigm Biopharmaceuticals has issued a Cleansing Notice related to the ...

Harvard/MIT’s startup supercluster is rapidly producing AI-era unicorns—often led by under-25 founders—with record growth ...

The Bihar verdict marks the culmination of an old political feud and signals the arrival of a new politics based on smart ...

This building-based DAC system is a revolutionary technology that could turn every home into an air pollution remediation ...

Good evening, dear friends, and thank you, Mr. Dean, for this warm introduction. And thank you all for coming. What a ...

Paradigm Gold Corporation (TSXV: PDQ) (“Paradigm” or the “Company”) has received Exchange approval to extend the closing of ...

Au10tix and representatives from Booking.com and evoke, got together with Biometric Update to present “How the world’s ...

A “quiet knee” rehabilitation protocol that limits passive range of motion, restricts ambulation and mandates aggressive ...

The 2025 HUAWEI XMAGE Awards Ceremony, alongside the "The World, You and Me" Annual Imaging Exhibition, opened on November 12 ...

Coastal geologist Stan Riggs shares an excerpt from his new book, "Cape Lookout National Seashore: Paradigm For A." ...